Qualigen Therapeutics to Present at the H.C. Wainwright BioConnect 2021 Conference
- 91
PR Newswire
CARLSBAD, Calif., Jan. 5, 2021
CARLSBAD, Calif., Jan. 5, 2021 /PRNewswire/ -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developing novel therapeutics for the treatment of cancer and infectious diseases, today announced that Michael Poirier, Chairman, Chief Executive Officer and President, will present at the H.C. Wainwright BioConnect 2021 Virtual Conference to be held January 11-14, 2021.
A webcast of the presentation will be accessible on demand beginning Monday, January 11, 2021 on the Qualigen Therapeutics website, https://www.qualigeninc.com/, in the Investors section.
View original content:http://www.prnewswire.com/news-releases/qualigen-therapeutics-to-present-at-the-hc-wainwright-bioconnect-2021-conference-301200916.html
SOURCE Qualigen, Inc.
PR Newswire es un distribuidor de comunicados de prensa con sede en la ciudad de Nueva York. El servicio se creó en 1954 para permitir que las empresas envíen comunicados de prensa electrónicamente a las organizaciones de noticias, al principio utilizando teleimpresores.
